CDC: ‘The Decision to Vaccinate Is a Personal One’
A recent CDC statement may signal a shift in the agency's longstanding practice of advocating vaccinations for infectious diseases like measles.
Tag: vaccine pneumococcal
All
Latest
CDC: ‘The Decision to Vaccinate Is a Personal One’
A recent CDC statement may signal a shift in the agency’s longstanding practice of advocating vaccinations for infectious diseases like measles.
Read More
American Confidence in RSV Vaccines Rises, Survey Finds
A new Annenberg Public Policy Center survey reveals evolving public attitudes toward vaccines—including RSV, flu, COVID-19, and MMR—in the United States.
Read More
CDC Lowers Age for Pneumococcal Vaccination from 65 to 50
Lowering the age gives more adults the opportunity to protect themselves from pneumococcal disease at an age when the risk of infection increases, according to the CDC.
Read More
ACP Urges Adults to Get Recommended Vaccinations
The American College of Physicians is advising adults to get all recommended vaccines to protect against preventable diseases and reduce the spread of infection.
Read More
FDA Approves Merck’s Pneumococcal Vaccine for Adults
The vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults 50 years of age and older.
Read More
FDA Grants Priority Review to Merck’s Pneumococcal Conjugate Vaccine for Adults
The FDA accepted for priority review a new Biologics License Application for V116, Merck’s investigational 21-valent pneumococcal conjugate vaccine designed to help prevent invasive pneumococcal disease and pneumococcal pneumonia in adults.
Read More
ATS Broadens Vaccine Push with Partnership from Five More Health Systems
The health systems will prioritize improving vaccine rates among high-risk adults with lung disease across different populations.
Read More
Common Vaccines May Shield Against Alzheimer’s Disease
A year after discovering that flu vaccines decrease the risk of Alzheimer’s disease by 40%, the same research team found that several other common vaccines also provide protective benefits.
Read More
FDA Approves 20-valent Pneumococcal Vaccine for Infants and Children
The vaccine builds on the company’s previously approved vaccine by including seven additional serotypes shown to be associated with antibiotic resistance, heightened disease severity, invasive potential, and prevalence in pediatric pneumococcal cases.
Read More
FDA Approves Vaxneuvance Pneumococcal Vaccine for Infants, Children
The FDA has expanded the approval for Merck’s Vaxneuvance for prevention of invasive disease caused by Streptococcus pneumoniae to include children 6 weeks through 17 years of age.
Read More
Pfizer COVID-19 and Pneumococcal Vaccines Safe to Co-administer
Pfizer’s Prevnar 20 pneumococcal vaccine can be safely co-administered with the Pfizer-BioNTech COVID-19 vaccine, according to a Phase 3 study.
Read More
Merck VaxNeuvance Pneumococcal Vaccine Approved in EU
The European Commission approved Merck’s VaxNeuvance (Pneumococcal 15-valent Conjugate Vaccine) for prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in individuals 18 years of age and older.
Read More
FDA Approves Prevnar 20 Pneumoccocal Vaccine
The US FDA has approved Pfizer’s Prevnar 20 Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia in adults age 18 and older.
Read More
Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate
Two Phase 3 studies of Merck’s investigational 15-valent pneumococcal conjugate vaccine met their primary immunogenicity objectives.
Read More
A Study of The Psychology of Anti-Vaxxers
People with vaccine skepticism overestimate the likelihood of all kinds of negative events, especially those that are rare, according to a new study published in the journal Vaccine.
Read More
FDA Urges Vaccinations for Back-to-School Season
“We cannot state strongly enough that overwhelming scientific evidence shows that vaccines are among the most effective and safest interventions, to both prevent individual illness and protect public health,” the FDA said.
Read MoreSeasonal Flu Vaccine May Cut Stroke Risk
Researchers in the UK found that patients who were vaccinated against influenza were 24% less likely to suffer a stroke in the same flu season.
Read More